Methods for Development of the European Commission Initiative on Breast Cancer Guidelines Recommendations in the Era of Guideline Transparency
Por:
Schunemann, HJ, Lerda, D, Dimitrova, N, Alonso-Coello, P, Grawingholt, A, Quinn, C, Follmann, M, Mansel, R, Sardanelli, F, Rossi, PG, Lebeau, A, Nystrom, L, Broeders, M, Ioannidou-Mouzaka, L, Duffy, SW, Borisch, B, Fitzpatrick, P, Hofvind, S, Castells, X, Giordano, L, Warman, S, Saz-Parkinson, Z, Autelitan, M, Colzani, E, Danes, J, Knox, S, Langendam, M, McGarrigle, H, Gomez, EP, Torresin, A, van Engen, R, Young, K, van Landsveld-Verhoeven, C, Rigau, D, Sola, I, Ballesteros, M, Arevalo-Rodriguez, I, Posso, M, Garcia, LM, Canelo-Aybar, C, de Guzman, EN, Valli, C, Ricci-Cabello, I, Superchi, C, Piggott, T, Baldeh, T, Parmelli, E, European Comm Initiative Breast
Publicada:
20 ago 2019
Resumen:
Neither breast cancer prevention and early-detection programs, nor their outcomes, are uniform across Europe. This article describes the rationale, methods, and process for development of the European Commission ( EC) Initiative on Breast Cancer Screening and Diagnosis Guidelines. To be consistent with standards set by the Institute of Medicine and others, the EC followed 6 general principles. First, the EC selected, via an open call, a panel with broad representation of areas of expertise. Second, it ensured that all recommendations were supported by systematic reviews. Third, the EC separately considered important subgroups of women, included patient advocates in the guidelines development group, and focused on good communication to inform women's decisions. Fourth, EC rules on conflicts of interest were followed and the GRADE ( Grading of Recommendations Assessment, Development and Evaluation) Evidence to Decision frameworks were used to structure the process and minimize the influence of competing interests. Fifth, it focused its recommendations on outcomes that matter to women, and certainty of the evidence is rated for each. Sixth, the EC elicited stakeholder feedback to ensure that the recommendations remain up to date and relevant to practice. This article describes the approach and highlights ways of disseminating and adapting the recommendations both within and outside Europe, using innovative information technology tools.
Filiaciones:
Schunemann, HJ:
McMaster Univ, Hlth Sci Ctr, Room 2C16,1280 Main St West, Hamilton, ON L8N 4K1, Canada
Lerda, D:
European Commiss, Joint Res Ctr, Via Enrico Fermi 2749,TP 127, I-21027 Ispra, VA, Italy
Dimitrova, N:
European Commiss, Joint Res Ctr, Via Enrico Fermi 2749,TP 127, I-21027 Ispra, VA, Italy
Alonso-Coello, P:
Iberoamer Cochrane Ctr, Biomed Res Inst IIB St Pau CIBERESP, St Antoni Maria Claret 167, Barcelona 8025, Spain
Grawingholt, A:
Radiol Theater, Neuer Pl 4, D-33098 Paderborn, NRW, Germany
Quinn, C:
St Vincents Univ Hosp, 96 Merrion Rd,Elm Pk, Dublin D04 T6F4, Ireland
Follmann, M:
German Canc Soc, Kuno Fischer Str 8, D-14057 Berlin, Germany
Mansel, R:
Cardiff Univ, Cardiff, S Glam, Wales
Cardiff Univ, The Gables NP25 3PA, Monmouth, Wales
Sardanelli, F:
Univ Milan, Via Morandi 30, I-20097 Milan, Italy
Rossi, PG:
Azienda Unita Sanitaria Locale IRCCS Reggio Emili, Via Amendola 2, I-42122 Reggio Emilia, Italy
Lebeau, A:
Univ Med Ctr Hamburg Eppendorf, Martinistr 52, D-20246 Hamburg, Germany
Private Grp Practice Pathol, Lubeck, Germany
Private Grp Practice Pathol, Hamburg, Germany
Nystrom, L:
Umea Univ, S-90187 Umea, Sweden
Broeders, M:
Radboud Univ Nijmegen, Med Ctr, Geert Grootepl 21, NL-6525 EZ Nijmegen, Netherlands
Dutch Expert Ctr Screening, Nijmegen, Netherlands
Ioannidou-Mouzaka, L:
Univ Athens, Sch Med, Athens, Greece
Leto Gynecol Surg & Obstet Clin, 18 Ave Kifissias, Athens 11526, Greece
Duffy, SW:
Queen Mary Univ London, Ctr Canc Prevent, Charterhouse Sq, London EC1M 6BQ, England
Queen Mary Univ London, London, England
Borisch, B:
Univ Geneva, Inst Global Hlth, Chemin Mines 9, CH-1202 Geneva, Switzerland
Fitzpatrick, P:
Natl Screening Serv, Kings Inns House,200 Parnell St, Dublin D01 A3Y8, Ireland
Hofvind, S:
Canc Registry Norway, PO 5313 Majorstua, N-0304 Oslo, Norway
Castells, X:
IMIM Hosp del Mar, Med Res Inst, Carrer Dr Aiguader 88, Barcelona 8003, Spain
IMIM, Barcelona, Spain
Giordano, L:
CPO Piedmont AOU Citta Salute & Sci, Via Cavour 31, I-10131 Turin, Italy
Warman, S:
Havyatt Rd, Langford BS40 5DD, North Somerset, England
Saz-Parkinson, Z:
European Commiss, Joint Res Ctr, Via Enrico Fermi 2749,TP 127, I-21027 Ispra, VA, Italy
Autelitan, M:
Canc Registry Milan, Milan, Italy
Colzani, E:
European Ctr Dis Control & Prevent ECDC, Stockholm, Sweden
Danes, J:
Charles Univ Prague, Prague, Czech Republic
Langendam, M:
Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
McGarrigle, H:
Univ Hosp Llandough, Cardiff & Vale Breast Ctr, Llandough, Penarth, Wales
Gomez, EP:
Univ Hosp Dr Josep Trueta, Girona, Spain
Torresin, A:
Osped Niguarda Ca Granda, Milan, Italy
van Engen, R:
Dutch Reference Ctr Screening, Nijmegen, Netherlands
Young, K:
Natl Coordinating Ctr Phys Mammog, Guildford, Surrey, England
van Landsveld-Verhoeven, C:
Dutch Reference Ctr Screening, Nijmegen, Netherlands
Rigau, D:
Iberoamer Cochrane Ctr, Barcelona, Spain
Sola, I:
Iberoamer Cochrane Ctr, IIB St Pau CIBERESP, Barcelona, Spain
Ballesteros, M:
Iberoamer Cochrane Ctr, Barcelona, Spain
Arevalo-Rodriguez, I:
Iberoamer Cochrane Ctr, IIB St Pau CIBERESP, Barcelona, Spain
Posso, M:
Iberoamer Cochrane Ctr, IIB St Pau, Barcelona, Spain
Garcia, LM:
Iberoamer Cochrane Ctr, IIB St Pau, Barcelona, Spain
Canelo-Aybar, C:
Iberoamer Cochrane Ctr, IIB St Pau, Barcelona, Spain
de Guzman, EN:
Iberoamer Cochrane Ctr, IIB St Pau, Barcelona, Spain
Valli, C:
Iberoamer Cochrane Ctr, IIB St Pau, Barcelona, Spain
Ricci-Cabello, I:
CIBERESP, Balear Isl Hlth Res Inst, Palma De Mallorca, Spain
Superchi, C:
Iberoamer Cochrane Ctr, IIB St Pau, Barcelona, Spain
Piggott, T:
McMaster Univ, Hlth Sci Ctr, Room 2C16,1280 Main St West, Hamilton, ON L8N 4K1, Canada
Baldeh, T:
McMaster Univ, Hlth Sci Ctr, Room 2C16,1280 Main St West, Hamilton, ON L8N 4K1, Canada
Parmelli, E:
European Commiss, Joint Res Ctr, Via Enrico Fermi 2749,TP 127, I-21027 Ispra, VA, Italy
|